SCHEMBL24330690

SCHEMBL24330690

Cc1cccc(C)c1-c1cc(Cl)nc(NS(=O)(=O)c2cccc(CO)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGES2 Q9H7Z7 1/20 0.41
▸ TSHR P16473 3/20 0.40
▸ IKBKB O14920 1/20 0.39
▸ PGR P06401 1/20 0.38
▸ PKM P14618 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ GAA P10253 2/20 0.38
▸ ACLY P53396 1/20 0.37
▸ ADRA2B P18089 1/20 0.37
▸ MAPT P10636 3/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ HTR6 P50406 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ PCTP Q9UKL6 1/20 0.37
▸ STARD10 Q9Y365 1/20 0.37
▸ KDM1A O60341 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24330665 0.89 TSHR (0.40) TSHRPGRPKMSMN1; SMN2GAA
SCHEMBL29703022 0.89 TSHR (0.40) TSHRPGRPKMSMN1; SMN2GAA
SCHEMBL26822143 0.86 CYTH2 (0.45) TSHRPKMSMN1; SMN2GAAACLY
SCHEMBL24325422 0.83 PKM (0.41) TSHRPKMSMN1; SMN2GAAACLY
SCHEMBL29447227 0.83 KDM4E (0.50) TSHRACLYKDM4EKMT2AALDH1A1
SCHEMBL22502033 0.83 KDM4E (0.50) TSHRACLYKDM4EKMT2AALDH1A1
SCHEMBL29570965 0.83 PKM (0.41) TSHRPKMSMN1; SMN2GAAACLY
SCHEMBL24299125 0.83 HDAC3 (0.42) PTGES2TSHRPKMSMN1; SMN2ACLY
SCHEMBL26838876 0.82 TSHR (0.40) TSHRPGRPKMSMN1; SMN2GAA
SCHEMBL22501936 0.82 SLC40A1 (0.49) TSHRSMN1; SMN2ACLYKMT2AKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225763-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076626-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
WO-2022076626-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback